Real-World First-Line Treatment Practices for BRAFV600E-Mutant Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world first-line treatment of patients with BRAFV600E-mutant metastatic colorectal cancer: the CAPSTAN CRC study
ESMO Open 2022 Nov 07;7(6)100603, E Martinelli, C Cremolini, T Mazard, J Vidal, I Virchow, D Tougeron, PJ Cuyle, B Chibaudel, S Kim, I Ghanem, B Asselain, C Castagné, A Zkik, S Khan, D ArnoldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.